Repository logo
 

Dopamine and memory dedifferentiation in aging.


Change log

Authors

Abdulrahman, Hunar 
Fletcher, Paul C 
Morcom, Alexa M 

Abstract

The dedifferentiation theory of aging proposes that a reduction in the specificity of neural representations causes declines in complex cognition as people get older, and may reflect a reduction in dopaminergic signaling. The present pharmacological fMRI study investigated episodic memory-related dedifferentiation in young and older adults, and its relation to dopaminergic function, using a randomized placebo-controlled double-blind crossover design with the agonist Bromocriptine (1.25mg) and the antagonist Sulpiride (400mg). We used multi-voxel pattern analysis to measure memory specificity: the degree to which distributed patterns of activity distinguishing two different task contexts during an encoding phase are reinstated during memory retrieval. As predicted, memory specificity was reduced in older adults in prefrontal cortex and in hippocampus, consistent with an impact of neural dedifferentiation on episodic memory representations. There was also a linear age-dependent dopaminergic modulation of memory specificity in hippocampus reflecting a relative boost to memory specificity on Bromocriptine in older adults whose memory was poorer at baseline, and a relative boost on Sulpiride in older better performers, compared to the young. This differed from generalized effects of both agents on task specificity in the encoding phase. The results demonstrate a link between aging, dopaminergic function and dedifferentiation in the hippocampus.

Description

Keywords

Aging, Dedifferentiation, Dopamine, Episodic memory, Hippocampus, Prefrontal cortex, Adult, Aged, Aging, Brain, Brain Mapping, Bromocriptine, Carrier Proteins, Dopamine, Dopamine Agonists, Dopamine Antagonists, Female, Humans, Male, Memory, Episodic, Middle Aged, Models, Neurological, Sulpiride, Young Adult

Journal Title

Neuroimage

Conference Name

Journal ISSN

1053-8119
1095-9572

Volume Title

Publisher

Elsevier BV
Sponsorship
Medical Research Council (G0001354)
Medical Research Council (MC_UU_12012/5/B)
Medical Research Council (G1000183)
Wellcome Trust (095692/Z/11/Z)
Medical Research Council (MC_UU_12012/5)
Medical Research Council (MC_PC_12012)
This research was funded mainly by a Fellowship to AMM from Research into Ageing, UK, and by an RCUK Academic Fellowship at the University of Edinburgh. Some of the research was conducted by Hunar Abdulrahman as part of a dissertation for the MSc in Neurosciences at the University of Edinburgh. The research was also supported by a Human Brain Project grant from the National Institute of Mental Health and the National Institute of Biomedical Imaging & Bioengineering. PCF was supported by a Wellcome Trust Senior Fellowship in Clinical Science, and by the Bernard Wolfe Health Neuroscience Fund. ETB is a part-time (50%) employee and shareholder of GSK. AMM is a member of the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross-council Lifelong Health and Wellbeing Initiative, Grant number G0700704/84698.